HIV-1 latency
HIV 1 latency in actively dividing human T cell lines
13
Identification of novel genes associated with HIV-1 latency by analysis of histone modifications
7
Cellular and molecular mechanisms involved in the establishment of HIV 1 latency
11
Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV 1 Latency
15
Gene silencing in HIV 1 latency by polycomb repressive group
7
Ex vivo analysis identifies effective HIV 1 latency–reversing drug combinations
13
Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins
19
The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency
11
HIV 1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells
22
Epigenetic Regulation of HIV-1 Latency in Astrocytes
8
Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency
11
Epigenetic control of HIV-1 post integration latency: implications for therapy
12
Combination of Biological Screening in a Cellular Model of Viral Latency and Virtual Screening Identifies Novel Compounds That Reactivate HIV-1
14
RNA induced epigenetic silencing inhibits HIV 1 reactivation from latency
18
Latency: the hidden HIV 1 challenge
9
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption
13
A novel HIV 1 encoded microRNA enhances its viral replication by targeting the TATA box region
15
Pharmacologic HIV-1 Nef blockade promotes CD8 T cell–mediated elimination of latently HIV-1–infected cells in vitro
19
HIV 1 transcription and latency: an update
38
Molecular control of HIV 1 postintegration latency: implications for the development of new therapeutic strategies
29